Reflect on the provided data and tweets to anticipate if the closing price of $bmy is going to increase or decrease at 2017-03-03. Kindly respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-16,1.5,1.6,-0.7,-1.4,-1.4,-1.7,-3.5,-5.5,-6.6,-4.6,-2.3
2017-02-17,-0.5,0.2,-0.9,0.6,0.6,-1.2,-3.4,-5.2,-6.7,-5.3,-3.2
2017-02-21,-0.7,4.4,-2.5,0.3,0.3,-0.6,-3.0,-4.8,-6.6,-5.7,-3.9
2017-02-22,0.3,2.0,-0.1,1.0,1.0,-1.0,-3.4,-5.1,-6.9,-6.8,-5.1
2017-02-23,-0.3,0.6,-1.3,0.8,0.8,-1.5,-3.4,-5.0,-7.1,-7.5,-6.1
2017-02-24,-0.9,0.1,-1.0,1.2,1.2,-1.9,-3.7,-5.4,-7.3,-8.5,-7.2
2017-02-27,-0.1,0.8,-0.6,0.2,0.2,-1.4,-3.0,-5.0,-6.8,-8.2,-7.4
2017-02-28,-0.3,0.4,-0.9,0.3,0.3,-1.0,-2.4,-4.5,-6.3,-8.0,-7.6
2017-03-01,-0.3,0.1,-1.2,0.8,0.8,-1.1,-2.6,-4.7,-6.4,-8.2,-8.3
2017-03-02,0.1,1.1,-0.5,-0.6,-0.6,-0.2,-1.8,-3.6,-5.2,-7.1,-7.8

2017-02-16: swing trade $bmy |valeant botches delayed brodaluma approval pr excluding amended license consideration $vrx $agn $myl $mrk $azn $bmy¡­ |any gypsy whispers out there on $bmy ?|#bristolmyerssquibb deut
2017-02-17: not sure why i keep getting this ad. is it because my brother has kidney cancer or because i bought $bmy last week?¡­ |add allergan's last couple of minutes of trading to the dosier! $agn $vrx $myl $m
2017-02-18: do you have a #global #strategy for #business #growth?  is here to help $teva $bmy $wfc #fridayfeeling|do you have a #global #strategy for #business #growth?  is here to help $teva $bmy $wfc #fridayfe
2017-02-19: 02/17/17 volume leader #84 - bmy 9,706,000 bristol-myers squibb company $bmy 54.59 +0.31 +0.57% high today of  |rt AT_USER $itrk .18 gone, .20 up, next trade could set a new hod. imo $itrk $gild $jnj 
2017-02-20: $bmy sum put vol=2,325 sum call vol=3,753 putcallratio=0.62 expiration 02/24/2017 .  |attractive call overwrites: $bmy calls more expensive than 95% of history, $mjn 93%, $shld 93%, $cl 89%, $mat 86%,
2017-02-21: rt AT_USER i shorted $bmy AT_USER ichan loves to play both sides|rt AT_USER $bmy spiking 2.2% on dow jones report carl icahn has taken stake, sees bmy as possible takeover target|AT_USER i think $bmy 
2017-02-22: #bristolmyerssquibb bristol-myers squibb company earns "buy" rating from argus. read more:  $bmy|marketcurrents: allergan's saunders: no interest in valeant  $agn $vrx $bmy|allergan's saunders: no int
2017-02-23: $bmy technicals are ugly though|$bmy holding a lot of cash, could be handy in this shifting environment bullish AT_USER|AT_USER what about $agn $bmy?|AT_USER recent textbook example was $bmy on jan 20
2017-02-24: rt AT_USER clovis oncology, inc. $clvs gets news from fda, merrill lynch  $ibb $xbi $atra exel $tsro $celg $bmy¡­|clovis oncology, inc. $clvs gets news from fda, merrill lynch  $ibb $xbi $atra exel $t
2017-02-25: benzinga: carl icahn's track record in big pharma  $bmy $lly $biib $sny $agn $azn|carl icahn's track record in big pharma  $bmy $lly $biib $sny $agn $azn|rt AT_USER pharmalot.. pharmalittle.. good mor
2017-02-27: rt AT_USER biotech partnering is a many-splendored thing  $exel $bmy #cancer |biotech partnering is a many-splendored thing  $exel $bmy #cancer |biotech partnering is a many-splendored thing  $exel $b
2017-03-01: rt AT_USER AT_USER $nwbo p3 trial could be halted by AT_USER any day due to overwhelming efficacy as $bmy #opdivo has #checkmat¡­|$bmy bristol-myers squibb to present data that advances understanding 
2017-03-02: 5 things for #pharma #marketers to know: thurs., mar. 2 $pfe $jnj $mrk $bmy $lly #drugpricing #patients $nvo¡­ |rt AT_USER why did infinity pharmaceuticals, inc. $infi gain +20%?  $bmy #cancer #biotec
Answer:
Reflect on the provided data and tweets to anticipate if the closing price of $bmy is going to increase or decrease at 2017-03-03. Kindly respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-16,1.5,1.6,-0.7,-1.4,-1.4,-1.7,-3.5,-5.5,-6.6,-4.6,-2.3
2017-02-17,-0.5,0.2,-0.9,0.6,0.6,-1.2,-3.4,-5.2,-6.7,-5.3,-3.2
2017-02-21,-0.7,4.4,-2.5,0.3,0.3,-0.6,-3.0,-4.8,-6.6,-5.7,-3.9
2017-02-22,0.3,2.0,-0.1,1.0,1.0,-1.0,-3.4,-5.1,-6.9,-6.8,-5.1
2017-02-23,-0.3,0.6,-1.3,0.8,0.8,-1.5,-3.4,-5.0,-7.1,-7.5,-6.1
2017-02-24,-0.9,0.1,-1.0,1.2,1.2,-1.9,-3.7,-5.4,-7.3,-8.5,-7.2
2017-02-27,-0.1,0.8,-0.6,0.2,0.2,-1.4,-3.0,-5.0,-6.8,-8.2,-7.4
2017-02-28,-0.3,0.4,-0.9,0.3,0.3,-1.0,-2.4,-4.5,-6.3,-8.0,-7.6
2017-03-01,-0.3,0.1,-1.2,0.8,0.8,-1.1,-2.6,-4.7,-6.4,-8.2,-8.3
2017-03-02,0.1,1.1,-0.5,-0.6,-0.6,-0.2,-1.8,-3.6,-5.2,-7.1,-7.8

2017-02-16: swing trade $bmy |valeant botches delayed brodaluma approval pr excluding amended license consideration $vrx $agn $myl $mrk $azn $bmy¡­ |any gypsy whispers out there on $bmy ?|#bristolmyerssquibb deut
2017-02-17: not sure why i keep getting this ad. is it because my brother has kidney cancer or because i bought $bmy last week?¡­ |add allergan's last couple of minutes of trading to the dosier! $agn $vrx $myl $m
2017-02-18: do you have a #global #strategy for #business #growth?  is here to help $teva $bmy $wfc #fridayfeeling|do you have a #global #strategy for #business #growth?  is here to help $teva $bmy $wfc #fridayfe
2017-02-19: 02/17/17 volume leader #84 - bmy 9,706,000 bristol-myers squibb company $bmy 54.59 +0.31 +0.57% high today of  |rt AT_USER $itrk .18 gone, .20 up, next trade could set a new hod. imo $itrk $gild $jnj 
2017-02-20: $bmy sum put vol=2,325 sum call vol=3,753 putcallratio=0.62 expiration 02/24/2017 .  |attractive call overwrites: $bmy calls more expensive than 95% of history, $mjn 93%, $shld 93%, $cl 89%, $mat 86%,
2017-02-21: rt AT_USER i shorted $bmy AT_USER ichan loves to play both sides|rt AT_USER $bmy spiking 2.2% on dow jones report carl icahn has taken stake, sees bmy as possible takeover target|AT_USER i think $bmy 
2017-02-22: #bristolmyerssquibb bristol-myers squibb company earns "buy" rating from argus. read more:  $bmy|marketcurrents: allergan's saunders: no interest in valeant  $agn $vrx $bmy|allergan's saunders: no int
2017-02-23: $bmy technicals are ugly though|$bmy holding a lot of cash, could be handy in this shifting environment bullish AT_USER|AT_USER what about $agn $bmy?|AT_USER recent textbook example was $bmy on jan 20
2017-02-24: rt AT_USER clovis oncology, inc. $clvs gets news from fda, merrill lynch  $ibb $xbi $atra exel $tsro $celg $bmy¡­|clovis oncology, inc. $clvs gets news from fda, merrill lynch  $ibb $xbi $atra exel $t
2017-02-25: benzinga: carl icahn's track record in big pharma  $bmy $lly $biib $sny $agn $azn|carl icahn's track record in big pharma  $bmy $lly $biib $sny $agn $azn|rt AT_USER pharmalot.. pharmalittle.. good mor
2017-02-27: rt AT_USER biotech partnering is a many-splendored thing  $exel $bmy #cancer |biotech partnering is a many-splendored thing  $exel $bmy #cancer |biotech partnering is a many-splendored thing  $exel $b
2017-03-01: rt AT_USER AT_USER $nwbo p3 trial could be halted by AT_USER any day due to overwhelming efficacy as $bmy #opdivo has #checkmat¡­|$bmy bristol-myers squibb to present data that advances understanding 
2017-03-02: 5 things for #pharma #marketers to know: thurs., mar. 2 $pfe $jnj $mrk $bmy $lly #drugpricing #patients $nvo¡­ |rt AT_USER why did infinity pharmaceuticals, inc. $infi gain +20%?  $bmy #cancer #biotec
Answer:+Rise